Molecular genetics of Alzheimer’s disease

[1]  E. Wijsman,et al.  Genetic association and linkage analysis of the apolipoprotein CII locus and familial Alzheimer's disease , 1992, Annals of neurology.

[2]  W. Bradley,et al.  Alzheimer's disease cells exhibit defective repair of alkylating agent—induced DNA damage , 1987, Annals of neurology.

[3]  S. Schneck,et al.  Twins with Alzheimer's disease. , 1981, Archives of neurology.

[4]  J. Hardy,et al.  APOLIPOPROTEIN-E GENOTYPE AND ALZHEIMERS-DISEASE , 1993 .

[5]  A. Schinzel,et al.  A molecular study of X isochromosomes: parental origin, centromeric structure, and mechanisms of formation. , 1991, American journal of human genetics.

[6]  Dementia of the Alzheimer type , 1987, Neurology.

[7]  M. Owen,et al.  Molecular genetics of Alzheimer's disease. , 1989, Biochemical Society transactions.

[8]  S. Gauthier,et al.  Apolipoprotein E polymorphism and Alzheimer's disease , 1993, The Lancet.

[9]  J. Hardy,et al.  Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene , 1991, Nature.

[10]  H. Wiśniewski,et al.  Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[11]  S. Tsuji,et al.  Mis-sense mutation Val→Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease , 1991, The Lancet.

[12]  S. Sorbi,et al.  Changes in Na+,K+-ATPase, Ca2+-ATPase and some soluble enzymes related to energy metabolism in brains of patients with Alzheimer's disease , 1990, Neuroscience Letters.

[13]  L. Fratiglioni,et al.  Risk factors for clinically diagnosed Alzheimer's disease , 1986, Neurology.

[14]  P. S. St George-Hyslop,et al.  Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. , 1987, Science.

[15]  J. Haines,et al.  The genetic defect in familial Alzheimer's disease is not tightly linked to the amyloid β-protein gene , 1987, Nature.

[16]  B. Winblad,et al.  A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid , 1992, Nature Genetics.

[17]  C. Finch,et al.  Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. , 1991, Brain research. Molecular brain research.

[18]  G. Schellenberg,et al.  Apolipoprotein E genotype and Alzheimer's disease , 1993, The Lancet.

[19]  S. Sorbi,et al.  Altered hexokinase activity in skin cultured fibroblasts and leukocytes from Alzheimer's disease patients , 1990, Neuroscience Letters.

[20]  J. Blass,et al.  Studies of transketolase abnormality in Alzheimer's disease. , 1988, Archives of neurology.

[21]  J. Growdon,et al.  Transmission and age‐at‐onset patterns in familial Alzheimer's disease , 1990, Neurology.

[22]  G. Schellenberg,et al.  Association of an apolipoprotein CII allele with familial dementia of the Alzheimer type. , 1987, Journal of neurogenetics.

[23]  C. Broeckhoven,et al.  Failure of familial Alzheimer's disease to segregate with the A4-amyloid gene in several European families , 1987, Nature.

[24]  Johannes Schottky Über präsenile Verblödungen , 1932 .

[25]  J. Haines,et al.  Molecular and prospective phenotypic characterization of a pedigree with familial Alzheimer's disease and a missense mutation in codon 717 of the β‐amyloid precursor protein gene , 1992, Neurology.

[26]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[27]  T. Koepsell,et al.  A case‐control study of Alzheimer's disease , 1990, Annals of neurology.

[28]  S. Sorbi,et al.  Clinical Aspects of Familial Forms of Alzheimer’s Disease , 1992 .

[29]  S. Sorbi,et al.  Growth properties of familial alzheimer skin fibroblasts during in vitro aging , 1992, Experimental Gerontology.

[30]  N. Sims,et al.  Altered metabolic properties of cultured skin fibroblasts in Alzheimer's disease , 1987, Annals of neurology.

[31]  B. Ghetti,et al.  A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. , 1991, Science.

[32]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.

[33]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[34]  A. Hofman,et al.  Familial aggregation of Alzheimer's disease and related disorders: a collaborative re-analysis of case-control studies. , 1991, International journal of epidemiology.

[35]  S. Sorbi,et al.  Alzheimer skin fibroblasts show increased susceptibility to free radicals , 1992, Mechanisms of Ageing and Development.

[36]  J. Hardy,et al.  Screening for the β-amyloid precursor protein mutation (APP717: Val → Ile) in extended pedigrees with early onset Alzheimer's disease , 1991, Neuroscience Letters.

[37]  K. Davis,et al.  Familial aggregation in Alzheimer's disease , 1988, Neurology.

[38]  A. D. Roses,et al.  Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .

[39]  J. Hardy,et al.  Alzheimer disease: the new agenda. , 1992, American journal of human genetics.

[40]  S. M. Sumi,et al.  Absence of linkage of chromosome 21q21 markers to familial Alzheimer's disease. , 1988, Science.

[41]  K. Grzeschik,et al.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.

[42]  James Scott Apolipoprotein E and Alzheimer's disease , 1993, The Lancet.

[43]  G. Vogler,et al.  Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world , 1992, Genetic epidemiology.

[44]  T. Ogihara,et al.  The 717Val----Ile substitution in amyloid precursor protein is associated with familial Alzheimer's disease regardless of ethnic groups. , 1991, Biochemical and biophysical research communications.

[45]  J. Fordtran,et al.  Quantitating the occult. , 1985, The New England journal of medicine.

[46]  M. Pericak-Vance,et al.  Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. , 1991, American journal of human genetics.

[47]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[48]  T. Muckle,et al.  HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IN DIFFERENTIAL DIAGNOSIS OF SENILE DEMENTIA , 1985, The Lancet.

[49]  B. Keats,et al.  Alzheimer disease: evidence for susceptibility loci on chromosomes 6 and 14. , 1983, American journal of human genetics.

[50]  Martin Farrall,et al.  PREDISPOSING LOCUS FOR ALZHEIMER'S DISEASE ON CHROMOSOME 21 , 1989, The Lancet.

[51]  J. Weber,et al.  Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. , 1992, Science.

[52]  E. Otomo,et al.  Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease , 1991, Brain Research.

[53]  I. Rainero,et al.  Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder , 1990, Nature.

[54]  J. Hardy,et al.  Screening for mutations in the open reading frame and promoter of the beta-amyloid precursor protein gene in familial Alzheimer's disease: identification of a further family with APP717 Val-->Ile. , 1992, Human molecular genetics.

[55]  M. Pericak-Vance,et al.  Apolipoprotein E ∈4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases , 1993, The Lancet.

[56]  S. Matsuyama,et al.  Organic brain syndrome and aging. A six-year follow-up of surviving twins. , 1980, Archives of general psychiatry.

[57]  J. Taylor,et al.  Nucleotide sequence and structure of the human apolipoprotein E gene. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[58]  M. Pericak-Vance,et al.  Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[59]  J. Blass,et al.  Altered calcium uptake in cultured skin fibroblasts from patients with Alzheimer's disease. , 1985, The New England journal of medicine.

[60]  D. Pollen,et al.  The genetic defect causing familial Alzheimer's disease maps on chromosome 21. , 1987, Science.

[61]  M. Lerman,et al.  Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. , 1987, Science.

[62]  S. Sorbi,et al.  APP717 and Alzheimer's disease in Italy , 1993, Nature Genetics.

[63]  D. Pollen,et al.  Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14 , 1992, Nature Genetics.

[64]  J. Ott,et al.  Multilocus linkage analysis in humans: detection of linkage and estimation of recombination. , 1985, American journal of human genetics.

[65]  C. Broeckhoven,et al.  Mapping of a gene predisposing to early–onset Alzheimer's disease to chromosome 14q24.3 , 1992, Nature Genetics.